We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
189 result(s) found, displaying 1 to 10
-
Prescription medicine registrationActive ingredients: selpercatinib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 120 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 40 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 160 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RETEVMO selpercatinib 80 mg film-coated tablets blister pack.
-
Sep-2025Prescription medicine evaluationActive ingredient: tirzepatide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen) (citrate-free formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation).